Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
about
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switchMechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancerType IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilumFrom an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaInternational network of cancer genome projects.Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndromeDBC2 is essential for transporting vesicular stomatitis virus glycoproteinGleevec inhibits beta-amyloid production but not Notch cleavageGATA-1 and Gfi-1B interplay to regulate Bcl-xL transcriptionEGFR inhibition in non-small cell lung cancer: resistance, once again, rears its ugly headImplications of growth factor alterations in the treatment of pancreatic cancerA screen to identify drug resistant variants to target-directed anti-cancer agentsThe steady progress of targeted therapies, promising advances for lung cancerEuropean LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaThe dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsThe Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyTargeting LKB1 in cancer - exposing and exploiting vulnerabilitiesUmbilical cord blood transplantation for the treatment of hematologic malignanciesReview article: the biology, diagnosis and management of gastrointestinal stromal tumoursMolecular mechanisms for survival regulation of chronic myeloid leukemia stem cellsRecurrent rearrangements in prostate cancer: causes and therapeutic potentialImatinib in chronic myeloid leukemia: an overviewThe next steps in next-gen sequencing of cancer genomesTargeting EML4-ALK driven non-small cell lung cancer (NSCLC)Medical management of metastatic medullary thyroid cancerThe role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignanciesPrimary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerThe BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer TherapeuticsCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaClonal evolution in hematological malignancies and therapeutic implicationsStructure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitorThe structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)Crystal Structures of ABL-Related Gene (ABL2) in Complex with Imatinib, Tozasertib (VX-680), and a Type I Inhibitor of the Triazole Carbothioamide ClassPhosphatidylinositol 3-kinase mutations identified in human cancer are oncogenicActivity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.Resistant mutations in CML and Ph(+)ALL - role of ponatinib.The Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung CancerTyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia: Long-Term Patient Care and Management
P2860
Q24302076-ED0B4A57-2550-4175-8144-944CE80B8239Q24302687-2094BD7E-F927-4BAA-BCDB-C2B6E9482299Q24604079-12463E5A-7625-4700-98AC-865AB1E56955Q24605527-C3DA0C5F-F17B-441F-9874-90DCEB6D613BQ24611474-89C4D334-D208-4D6D-92FE-08CFBC5952F8Q24670121-C4BA9632-7C1F-495A-87BB-1536EEB66CC5Q24679763-9BA467D4-D040-4DBD-819D-DD5893C24404Q24683037-8BA0A84C-803A-49F9-B139-FB0A769D445AQ24683168-88F1BA77-0384-467E-B07D-A17EB2A96717Q24794815-C97B892E-F5A9-491D-8D3B-73A66BD2CB70Q24800145-B55BDFB5-DC74-4772-AF19-74990082A386Q24806543-526D20DF-0432-4F6E-841C-283F0B261BD8Q26746895-7A1854C4-FEC1-4FB8-B595-6B7634620C04Q26749324-F5C0F974-5BC7-4755-BB17-920F3E75FD34Q26753387-9A27DF16-2CFD-4C75-B407-43341B1AF541Q26799596-FC253F86-787B-45DE-B2A0-F1584315FDECQ26801412-85EE46B9-8584-422B-B5E8-686D19DB44E4Q26820829-456D30E3-C753-48C1-AEBF-FBFFD4CDC396Q26825310-E2840283-9620-4DF4-B941-97535B4A388BQ26828528-B54D91AA-2476-4A4E-B6F4-5FBAF5A4F176Q26851525-33D08E24-A571-4F96-9725-C4D39F8E8299Q26865086-751B53DD-68DE-44F0-8439-ABEA5195993BQ26998894-1BCDAAE5-1F02-4B1F-950E-07038B41829FQ27002155-A1227513-5412-45C7-A620-72984A7F0C58Q27005897-CB6748E4-C2E3-42C1-B81B-C79804EB5BF6Q27008221-003E9EA7-EF00-4E4D-8300-B430A7259F81Q27009148-B86A06E7-E114-44E8-82B1-96BC20BB32EEQ27010154-29E004DB-FA1D-4689-8EEB-4E26EE33B1C4Q27025242-B5C97F7B-A65E-4221-B598-FD5BEEB7892DQ27027655-19251AE0-5651-4C3A-A6AF-187BFE524CDFQ27639528-07DD0306-D49A-469D-A0C0-80ED3D1A0F33Q27653890-54C187D4-6CEF-444B-8D33-A88E70236D88Q27667290-B01F9A1F-1EF5-4D8C-866B-B31DE40637FCQ27824826-80A021BF-9D27-4EFE-B8CB-2BEBCC2F38D4Q27851585-2CD90864-38DC-4EAB-87A3-10563A2543A8Q27851628-261DFCD7-1CA2-42B1-8651-D13B5136F720Q27852644-71EA89A5-1A47-431A-99AF-89520E5C220BQ27853085-F1D413B9-0DE1-4896-9DF7-320B38DB511EQ28067196-8750B98B-96D9-4727-8568-F0DFB3F235EFQ28075963-6B1C31A3-135E-40FA-9CF9-03AEA5CDCC8A
P2860
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@ast
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@en
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@nl
type
label
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@ast
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@en
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@nl
prefLabel
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@ast
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@en
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@nl
P2093
P1476
Activity of a specific inhibit ...... h the Philadelphia chromosome.
@en
P2093
Capdeville R
Kantarjian H
Sawyers CL
P304
P356
10.1056/NEJM200104053441402
P407
P577
2001-04-01T00:00:00Z